(Total Views: 463)
Posted On: 08/19/2025 9:32:22 PM
Post# of 156142
Something big is going to develop because using a hypothetical 12 months, or even 18 months to a FDA approval(s) on CRC or mTNBC, no new mfgr facility can be built in that time.
Also, FDA will still need to approve any current mfgr facilities that Cytodyn would partner with for producing commercial market Leronlimab.
The latest filing touched on this.
Combined with funding needs, both show big clues of significant partnerships are in-coming.
If mgt thinks there is a very high probability of Accelerated Approval(s), then manufacturing is also in discussions. Cold to Hot verified & the scale of mfgr'n needed, says all around, only Tier 1 partnerships are on-deck....
Ready for Cold to Hot verification!!
Also, FDA will still need to approve any current mfgr facilities that Cytodyn would partner with for producing commercial market Leronlimab.
The latest filing touched on this.
Combined with funding needs, both show big clues of significant partnerships are in-coming.
If mgt thinks there is a very high probability of Accelerated Approval(s), then manufacturing is also in discussions. Cold to Hot verified & the scale of mfgr'n needed, says all around, only Tier 1 partnerships are on-deck....
Ready for Cold to Hot verification!!
(5)
(0)
